Parkinson Society Canada’s leadership, in bringing neurological charities together, has resulted in the establishment of Neurological Health Charities Canada (NHCC), a new collective of 15 organizations that represent Canadians with chronic, often progressive, brain diseases, disorders and injuries. NHCC’s role is to provide leadership, evaluating and advancing new opportunities for collaboration specific to advocacy, education … Read more

Telemedicine improves access for people with Parkinson’s Almost every afternoon, Dr. Mark Guttman closes his office door at the Centre for Movement Disorders clinic in Markham and turns on the TV. The waiting room may be empty, but he still has patients to see – via the Ontario Telemedicine Network. Dr. Guttman describes how it … Read more

Azilect® reported to have potential to affect progression On August 26, 2008 a news release issued by Teva Pharmaceutical Industries Ltd., manufacturers of the drug, Azilect®, reports that the results of the ADAGIO phase 3 trial indicate that early treatment with 1 mg of Azilect supports the potential for Azilect to have an effect on the … Read more

A man is sitting in an armchair in his living room when he hears the phone ringing in the kitchen. He rises apprehensively from his chair to make his way to the telephone. Suddenly, he is tackled by an intruder who physically prevents him from getting to the phone. Books, plates and chairs come crashing … Read more

Partnering on research initiatives allows Parkinson Society Canada (PSC) to invest more money into more research that will ultimately benefit the over 100,000 Canadians living with Parkinson’s, their care partners, and families. It is the cornerstone of what we do as the largest non-government funder of Parkinson’s research in Canada.   Canadian Institutes of Health … Read more